We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Policy

Cannabis Policy

Canadian Regulators Recall Cannabis Pre-rolls Due to Mold Concerns

Approximately 11,304 of the products were sold across Alberta, the Northwest Territories, and Yukon between December 2020 and July 2021.

Read More

Sapphire Medical Clinics Launches New Education Service for Patients

Sapphire Medical Clinics, the first specialized medical cannabis clinic in the UK approved to see patients by the Care Quality Commission, has launched another educational platform for patients.

Read More

Rwanda Legalizes Medical Cannabis

Doctors in Rwanda can now prescribe medical cannabis to patients, following a new ministerial order passed by legislators to recognize the medical value of the plant and legalize its medicinal use.

Read More

Colorado Announces New THC Testing Rules for Hemp Products

Some of the requirements are stricter than the equivalent rules for cannabis products.

Read More

Pennsylvania Expands Medical Cannabis Regulations

The bill also permits cannabis companies to remediate their products by extracting them into a topical form should they be contaminated with yeast or mold.

Read More

New Colorado Law Restricts Concentrate Sales

Coming into effect on January 1, 2022, the bill will limit patients aged 21 and over to 8 grams of concentrates per purchase, down from the previous limit of 40 grams.

Read More

Mexico’s Supreme Court Decriminalizes Cannabis

Mexico’s Supreme Court has removed the laws prohibiting the use of recreational cannabis, effectively decriminalizing the drug for adults.

Read More

UN Calls for Ban on Cannabis Advertising

The World Drug Report 2021 from the UN’s Office on Drugs and Crime (UNODC) claims that such a ban would “ensure that public health interests prevail over business interests.”

Read More

 
Advertisement